Overview
Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in Children
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2023-03-01
2023-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Local anaesthesia is considered one of the most alarming and non-comfortable dental procedures for children. This goes back to the persisting effect of the local anaesthesia after finishing dental procedures. The effect of Local anaesthesia can last from 3 to 5 hours due to the presence of vasoconstrictor. The U.S Food and Drug Administration (FDA approved the use of phentolamine mesylate (Oraverse) in May 2008 to be used as a drug in reversing the numbing effect of Local anaesthesia by decreasing the time needed to restore the normal functions of the mouthPhase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Cairo UniversityTreatments:
Phentolamine
Criteria
Inclusion Criteria:Children aged 6-8 years.
- Patients in need of dental procedures requiring local anaesthesia.
- Healthy Children without any systemic or mental disorders.
- Normal lip sensation before administration of LA.
- Normal paediatric functional assessment battery (pFAB) for smiling, speaking and
drinking and absence of drooling.
Exclusion Criteria:
- Children seeking dental treatment that does not necessitate local anaesthesia.
- Children who didn't achieve profound numbness requiring additional anaesthesia.
- Children who lack the ability to distinct the anaesthetised numb side from the
non-anaesthetised one.
- Children who are not willing to participate in the study.